Antimitotic Agents: all 5,052 studies that test it

Page 18 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)TerminatedNCT00215943Phase 3Results posted
• The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung CancerCompletedNCT00215930Phase 2Results posted
• A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell LymphomaCompletedNCT00211185Phase 2Results posted
• Randomized Phase II Trial Induction Therapy for Early Stage Breast CancerCompletedNCT00209092Phase 2Results posted
• Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced CancerCompletedNCT00207090Phase 1Results posted
• Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer PatientsCompletedNCT00206518Phase 2Results posted
• Primary Systemic Therapy in Operable/Locally Advanced Breast CancerCompletedNCT00203502Phase 2Results posted
• A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer PatientsCompletedNCT00201825Phase 2Results posted
• Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown PrimaryTerminatedNCT00201734Phase 1/2Results posted
• Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast CancerTerminatedNCT00194792Phase 2Results posted
• Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By SurgeryCompletedNCT00194779Phase 2Results posted
• Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary SiteCompletedNCT00193596Phase 3Results posted
• Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung CancerCompletedNCT00193453Phase 2Results posted
• Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung CancerCompletedNCT00193427Phase 2Results posted
• Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast CancerCompletedNCT00193206Phase 2Results posted
• Docetaxel Plus Imatinib Mesylate in Metastatic Breast CancerCompletedNCT00193180Phase 2Results posted
• Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast CancerCompletedNCT00193050Phase 2Results posted
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast CancerCompletedNCT00193037Phase 2Results posted
• Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st LineCompletedNCT00191854Phase 2Results posted
• Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00191139Phase 2Results posted
• Study of Treatment for Patients With Cancer of the Eye -RetinoblastomaCompletedNCT00186888Phase 3Results posted
• Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00186875Phase 2Results posted
• Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00184028Phase 2Results posted
• Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's LymphomasCompletedNCT00184002Phase 2Results posted
• Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate CancerTerminatedNCT00183937Phase 2Results posted
• Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00183872Phase 2Results posted
• Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian CancerCompletedNCT00182767Phase 1/2Results posted
• Study of Long-term Peg Intron vs. Colchicine in Non-responders.CompletedNCT00179413Phase 4Results posted
• Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung CancerCompletedNCT00178256Phase 1/2Results posted
• A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus CancersTerminatedNCT00177255Phase 2Results posted
• Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00176631Phase 2Results posted
• Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerTerminatedNCT00176488Phase 2Results posted
• Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck CancerCompletedNCT00176254Phase 2Results posted
• Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung CancerCompletedNCT00171834Phase 1/2Results posted
• Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell FunctionTerminatedNCT00169104Phase 2/3Results posted
• Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.CompletedNCT00162136Phase 1Results posted
• Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal CancerCompletedNCT00159484Phase 1/2Results posted
• Taxol Carboplatin and ErythropoetinCompletedNCT00158379Phase 2Results posted
• Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)CompletedNCT00148798Phase 3Results posted
• Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast CancerCompletedNCT00148668Phase 2Results posted
• A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck CancerCompletedNCT00148122Phase 2Results posted
• Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung CancerTerminatedNCT00145418Phase 2Results posted
• Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic DysfunctionCompletedNCT00145041Phase 1Results posted
• Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical CancerTerminatedNCT00138151Phase 2Results posted
• Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate CancerCompletedNCT00137436Phase 1/2Results posted
• Therapy for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedNCT00137111Phase 3Results posted
• Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or MyelodysplasiaCompletedNCT00136084Phase 3Results posted
• Chemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaCompletedNCT00132301Phase 3Results posted
• Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)CompletedNCT00129727Phase 2Results posted
• FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer PatientsCompletedNCT00129389Phase 3Results posted
• Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00129376Phase 2Results posted
• Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung CancerCompletedNCT00126581Phase 2Results posted
• Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent RestenosisCompletedNCT00124943Phase 1/2Results posted
• Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant TreatmentCompletedNCT00121992Phase 3Results posted
• Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell LymphomaCompletedNCT00121199Phase 2Results posted
• Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerCompletedNCT00119262Phase 2Results posted
• Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00118131Phase 2Results posted
• Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast CancerTerminatedNCT00118053Phase 2Results posted
• Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate CancerCompletedNCT00116142Phase 3Results posted
• Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine CancerCompletedNCT00114218Phase 2Results posted
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryTerminatedNCT00113399Phase 3Results posted
• Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine CancerCompletedNCT00112489Phase 2Results posted
• ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNCT00110084Phase 2Results posted
• S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00109837Phase 2Results posted
• S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00107380Phase 2Results posted
• Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin DiseaseCompletedNCT00107198Phase 2Results posted
• Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell TumorsCompletedNCT00104676Phase 3Results posted
• SB-715992 in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00103311Phase 2Results posted
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00103285Phase 3Results posted
• Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell LymphomaCompletedNCT00101101Phase 2Results posted
• Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet ChemotherapyCompletedNCT00100932Phase 2Results posted
• S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerCompletedNCT00100789Phase 2Results posted
• A Study of E7389 in Advanced/Metastatic Breast Cancer PatientsCompletedNCT00097721Phase 2Results posted
• Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00096200Phase 2Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or TestesCompletedNCT00096135Not applicableResults posted
• Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00095979Phase 2Results posted
• Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)CompletedNCT00095875Phase 3Results posted
• SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00095628Phase 2Results posted
• Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung CancerCompletedNCT00095199Phase 3Results posted
• Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00094835Phase 1/2Results posted
• Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00093808Phase 2Results posted
• Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast CancerCompletedNCT00093795Phase 3Results posted
• Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung CancerCompletedNCT00093756Phase 1/2Results posted
• Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast CancerCompletedNCT00093145Phase 2Results posted
• Second-Line Treatment for Patients With Platinum-Sensitive Ovarian CancerCompletedNCT00090610Phase 2Results posted
• Study Of Ispinesib In Subjects With Breast CancerCompletedNCT00089973Phase 2Results posted
• Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck CancerCompletedNCT00089297Phase 2Results posted
• Genetic Testing in Predicting Response to Paclitaxel in Women With Breast CancerTerminatedNCT00088829Phase 2Results posted
• BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNCT00088530Phase 3Results posted
• Ixabepilone in Treating Patients With Metastatic Prostate CancerCompletedNCT00087139Phase 2Results posted
• Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00086957Phase 1/2Results posted
• Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorCompletedNCT00085202Phase 3Results posted
• Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RTCompletedNCT00084838Phase 2Results posted
• Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and NeckCompletedNCT00084318Phase 2Results posted
• UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation ChemotherapyCompletedNCT00083551Phase 3Results posted
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT00082433Phase 3Results posted
• Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT00080301Phase 3Results posted
• Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular RetinoblastomaCompletedNCT00079417Phase 3Results posted
• Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast CancerTerminatedNCT00079326Phase 2Results posted
• A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00077857Phase 2Results posted

← Antimitotic Agents overview